MICHAEL DIAZ MD NPI 1871574186

NPI Details

Michael Diaz, MD is a medical oncology internal medicine in St Petersburg, FL with 27 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Michael Diaz, MD NPI is 1871574186. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KENTUCKY COLLEGE OF MEDICINE
Graduation Year:1999

The provider's business location address is:

1201 5TH AVE N STE 505
ST PETERSBURG, FL
ZIP 33705-455
Phone: (727) 821-0017
Fax: (727) 821-7473

The NPI 1871574186 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ferritin (blood protein) level (HCPCS:82728)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron level (HCPCS:83540)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Magnesium level (HCPCS:83735)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Folic acid level, serum (HCPCS:82746)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Protein measurement, serum (HCPCS:84165)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Automated urinalysis test (HCPCS:81003)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, clotting time (HCPCS:85610)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection of drug or substance into vein (HCPCS:96374)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Iron binding capacity (HCPCS:83550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Urinalysis, manual test (HCPCS:81002)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Red blood count, automated test (HCPCS:85045)

The enumeration date for this NPI number is 11/14/2005 and was last updated on 5/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.